| Drug and disease signature integration identifies synergistic combinations in glioblastoma V Stathias, AM Jermakowicz, ME Maloof, M Forlin, W Walters, RK Suter, ... Nature communications 9 (1), 5315, 2018 | 100 | 2018 |
| Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex E Leung, L Guo, J Bu, M Maloof, J El Khoury, C Geula Neurobiology of aging 32 (3), 387-397, 2011 | 48 | 2011 |
| Casein kinase 1δ Is an APC/CCdh1 substrate that regulates cerebellar granule cell neurogenesis C Penas, EE Govek, Y Fang, V Ramachandran, M Daniel, W Wang, ... Cell reports 11 (2), 249-260, 2015 | 41 | 2015 |
| Epigenetic pathways and glioblastoma treatment: insights from signaling cascades BK Allen, V Stathias, ME Maloof, D Vidovic, EF Winterbottom, ... Journal of cellular biochemistry 116 (3), 351-363, 2015 | 30 | 2015 |
| Time series modeling of cell cycle exit identifies Brd4 dependent regulation of cerebellar neurogenesis C Penas, ME Maloof, V Stathias, J Long, SK Tan, J Mier, Y Fang, ... Nature communications 10 (1), 3028, 2019 | 29 | 2019 |
| Bromodomain protein BRD4 is essential for hair cell function and survival A Kannan-Sundhari, C Abad, ME Maloof, NG Ayad, JI Young, XZ Liu, ... Frontiers in cell and developmental biology 8, 576654, 2020 | 5 | 2020 |
| Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping H Yang, P Sui, Y Guo, S Chen, ME Maloof, G Ge, F Nihozeko, CR Delma, ... EMBO reports 24 (10), e57032, 2023 | 2 | 2023 |
| Activity of selinexor as a single agent and synergistic activity with approved/investigational myelofibrosis therapies in vitro MEE Maloof, S Wu, A Ellero, CJ Walker, S Kye, P Taverna Blood 142, 6353, 2023 | 1 | 2023 |
| Selinexor synergizes with anti-PD-1 antibody and inhibits tumor growth and metastasis in syngeneic mouse models of KRAS mutant colorectal cancer H Chang, L Henegar, CJ Walker, T Kashyap, M Maloof, F Wang, K Martyn, ... AACR Cancer Research 82 (12_Supplement), 5519-5519, 2022 | 1 | 2022 |
| Abstract C005: TP53 wildtype status can predict sensitivity to XPO1 inhibitors in Patient-Derived Cancer Models M Maloof, A Ellero, P Taverna, CJ Walker Molecular Cancer Therapeutics 22 (12_Supplement), C005-C005, 2023 | | 2023 |
| Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma L Graves, G Rupprecht, E Altunel, EM Flamant, S Rao, D Sivara, ... AACR Cancer Research 82 (12_Supplement), 1061-1061, 2022 | | 2022 |
| Selinexor synergizes with IL-12 to inhibit tumor growth in syngeneic mouse models of melanoma S Orr, L Henegar, CJ Walker, F Wang, T Kashyap, M Maloof, K Martyn, ... AACR Cancer Research 82 (12_Supplement), 1122-1122, 2022 | | 2022 |
| Selinexor synergizes with temozolomide in preclinical models of glioblastoma independent of MGMT promoter methylation L Henegar, H Chang, CJ Walker, T Kashyap, M Maloof, F Wang, K Martyn, ... AACR Cancer Research 82 (12_Supplement), 6023-6023, 2022 | | 2022 |
| Synergistic anti-cancer effects of selinexor and bevacizumab in mouse xenograft models of glioblastoma L Henegar, H Chang, CJ Walker, T Kashyap, M Maloof, F Wang, K Martyn, ... AACR Cancer Research 82 (12_Supplement), 6022-6022, 2022 | | 2022 |
| Nuclear export inhibitor selinexor synergizes with proteasome inhibitor marizomib in preclinical models of glioblastoma H Chang, L Henegar, CJ Walker, T Kashyap, M Maloof, F Wang, K Martyn, ... AACR Cancer Research 82 (12_Supplement), 5455-5455, 2022 | | 2022 |
| Brd4 Is Required for Granule Cell Progenitor Proliferation ME Maloof University of Miami, 2019 | | 2019 |
| GENE-07. EPIGENETIC PATHWAYS CONTROLLING HOTAIR EXPRESSION IN GLIOBLASTOMA SK Tan, C Pastori, M Maloof, N Ayad Neuro-Oncology 19 (Suppl 6), vi93, 2017 | | 2017 |
| A cell based screening approach for identifying protein degradation regulators S Simanski, ME Maloof, TK Sato, V Cavett, J Caldwell Busby, NG Ayad Cell Cycle 16 (10), 940-946, 2017 | | 2017 |
Nagi Ayad在 georgetown.edu 的电子邮件经过验证
